MEI Pharma Pioneers Litecoin Treasury Strategy With $100 Million Commitment, Stock Surges

MEI Pharma (MEIP), a NASDAQ-listed pharmaceutical company, has finalized a $100 million private placement to initiate a pioneering Litecoin (LTC) treasury strategy. Since announcing its pivot toward adopting LTC as a reserve asset, the firm’s stock price has surged. Over the past five days, MEIP has pumped over 100%, signaling investor confidence in the firm’s decision. MEI Pharma Commits $100 Million to Buy Litecoin  According to the official press release, MEI Pharma entered into securities purchase agreements with investors on July 18 source: https://beincrypto.com/mei-pharma-litecoin-treasury-strategy/